Pfizer EPS - Earnings per Share 2010-2025 | PFE

Pfizer earnings per share (EPS) for the twelve months ending March 31, 2025 was $1.38, a 2860% decline year-over-year.

  • Pfizer EPS for the quarter ending March 31, 2025 was $0.52, a 5.45% decline year-over-year.
  • Pfizer 2024 annual EPS was $1.41, a 281.08% increase from 2023.
  • Pfizer 2023 annual EPS was $0.37, a 93.24% decline from 2022.
  • Pfizer 2022 annual EPS was $5.47, a 42.08% increase from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

Pfizer EPS - Earnings per Share 2010-2025 | PFE

  • Pfizer EPS for the quarter ending March 31, 2025 was $0.52, a 5.45% decline year-over-year.
  • Pfizer 2024 annual EPS was $1.41, a 281.08% increase from 2023.
  • Pfizer 2023 annual EPS was $0.37, a 93.24% decline from 2022.
  • Pfizer 2022 annual EPS was $5.47, a 42.08% increase from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$731.4B
Johnson & Johnson (JNJ)$373.4B
AbbVie (ABBV)$329.2B
Novo Nordisk (NVO)$300.1B
Novartis AG (NVS)$252.8B
Roche Holding AG (RHHBY)$252.8B
Merck (MRK)$204.7B
Sanofi (SNY)$118B
Bayer (BAYRY)$31.1B
Innoviva (INVA)$1.3B